Ciprofibrate (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C10AB08
CAS registry number (Chemical Abstracts Service)
0052214-84-3
Chemical Formula
C13-H14-Cl2-O3
Molecular Weight
289
Therapeutic Category
Lipid lowering: Fibrate
Chemical Name
Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-metyl-
Foreign Names
- Ciprofibratum (Latin)
- Ciprofibrat (German)
- Ciprofibrate (French)
- Ciprofibrato (Spanish)
Generic Names
- Ciprofibrate (OS: USAN, DCF, BAN)
- Win 35833 (Winthrop) (IS)
- Ciprofibrate (PH: BP 2018, Ph. Eur. 9)
- Ciprofibratum (PH: Ph. Eur. 9)
Brand Names
- Alipidem
Iqfarma, Peru - Cerolip
Difare, Ecuador - Cetaxin
AC Farma, Peru - Cibrato
Mantecorp FSA, Brazil - Cipide
Aché, Brazil - Ciprofibraat Amdipharm
Amdipharm, Netherlands - Ciprofibrate
Concordia, United Kingdom; Zentiva, United Kingdom - Ciprofibrate Arrow
Arrow, France - Ciprofibrate Biogaran
Biogaran, France - Ciprofibrate Mylan
Mylan, Belgium; Mylan, France - Ciprofibrate Sandoz
Sandoz, France - Ciprofibrate Zentiva
Sanofi-Aventis, France - Ciprofibrato
Caferma, Peru; Sanofi-Aventis Farmaceutica, Brazil - Ciprofibrato Ache
Aché, Brazil - Ciprofibrato Biosintetica
Biosintética, Brazil - Ciprofibrato Farmandina
Farmandina, Guatemala - Ciprofibrato GeoLab
GeoLab, Brazil - Ciprofibrato La Santé
La Santé, Colombia; La Santé, Costa Rica; La Santé, Nicaragua; La Santé, El Salvador - Ciprofibrato Medley
Medley, Brazil - Ciprofibrato Merck
Merck, Brazil - Ciprofibrato MK
MK, Colombia - Ciprofibrato Neo Quimica
Neo Química, Brazil - Ciprofibrato PL
Paill, El Salvador - Ciprofibrato Vitamedic
Vitamedic, Brazil - Ciprolip
UCI-Farma, Brazil - Dislipen
Biogaran, Paraguay - Dublina
Pharma Investi de Chile, Chile - Espabinol
Panalab, Peru - Estabinol
Panalab, Peru - Estaprol
Sanofi Aventis, Chile; Sanofi-Aventis, Argentina; Sanofi-Aventis, Uruguay - Fibrolip
Garmisch, Colombia; Noas Farma, Uruguay - Fixeril
Lazar, Argentina; Lazar, Uruguay - Floxar SR
Joswe Medical, Lebanon - Giabri
Merck, Chile; Merck, Colombia; Merck, Ecuador; Merck, Peru - Hiperlipen
Sanofi, Dominican Republic; Sanofi, Guatemala; Sanofi, Panama; Sanofi-Aventis, Colombia; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Honduras; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Peru; Sanofi-Aventis, Paraguay; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Venezuela - Hyperlipen
Sanofi Belgium, Belgium - Hyperlipen-100
Sanofi Belgium, Luxembourg - Lipanor
CTS, Israel; Sanofi, Portugal; Sanofi Aventis, Tunisia; Sanofi Winthrop, Bulgaria; Sanofi Winthrop, Macedonia; Sanofi Winthrop, Serbia; Sanofi-Aventis, Bosnia & Herzegowina; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, France; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Poland - Lipanor 100 mg
Sanofi-Aventis, Hungary - Lipobrand
PharmaBrand, Ecuador - Lipodex
Unipharm, Guatemala; Unipharm, Honduras; Unipharm, Nicaragua; Unipharm, El Salvador - Lipofibrato
Maquifarma, Peru - Modalim
Sanofi Aventis, China; Sanofi Winthrop, Kuwait; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Singapore; Sanofi-Aventis Netherlands, Netherlands; Sanofi-Synthelabo, Lebanon - Oroxadin
Sanofi-Aventis, Mexico - Trifolget
Caferma, Peru
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.